Glenna Mileson

Insider Reports History

Location
Seattle, WA
Signature
/s/ Glenna Mileson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Glenna Mileson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Athira Pharma, Inc. Chief Financial Officer Stock Option (Right to Buy) 150,000 19 Jan 2023 Direct

Insider Reports Filed by Glenna Mileson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATHA Athira Pharma, Inc. 19 Jan 2023 1 $0 4 Chief Financial Officer 23 Jan 2023, 16:51
ATHA Athira Pharma, Inc. 28 Dec 2022 2 +$144,341 4 Chief Financial Officer 30 Dec 2022, 15:58
ATHA Athira Pharma, Inc. 22 Jun 2022 3 +$5,119 4 Chief Financial Officer 24 Jun 2022, 19:53
ATHA Athira Pharma, Inc. 12 Apr 2022 2 +$31,920 4 Chief Financial Officer 12 Apr 2022, 19:36
ATHA Athira Pharma, Inc. 18 Jan 2022 1 $0 4 Chief Financial Officer 20 Jan 2022, 16:28
ATHA Athira Pharma, Inc. 04 Jan 2022 3 +$20,159 4 Chief Financial Officer 06 Jan 2022, 16:08
ATHA Athira Pharma, Inc. 18 May 2021 3 +$30,967 4 Chief Financial Officer 10 Jun 2021, 18:48